Figure 1.
Low testosterone (T) predicts increased mortality and testosterone therapy improves survival in 587 men with type 2 diabetes (mean follow up: 5.8 years) [Muraleedaran et al. 2013].
Low testosterone (T) predicts increased mortality and testosterone therapy improves survival in 587 men with type 2 diabetes (mean follow up: 5.8 years) [Muraleedaran et al. 2013].